RxDoctor Payments Data

Christopher Jones, MD

Family Medicine · Bay St Louis, MSNPI 1609076124

Payments from drug & device makers

$242in general payments, 2019–2025

Across 15 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$66
  • Novo Nordisk$46
  • Dynavax Technologies Corporation$28
  • Antares Pharma, Inc.$22
  • Abbott$22
  • GSK$20
  • plus $38 from 3 others

What the payments were for

  • Food & beverage$242100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$242 in reported general payments places this provider in the 35th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$91,487
Medicare patients
160
Services billed
2,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$46,873
JardianceEmpagliflozin30$23,162
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$18,173
EliquisApixaban20$17,250
TrulicityDulaglutide12$11,538
Tresiba Flextouch U-100Insulin Degludec16$9,352
Breo ElliptaFluticasone/Vilanterol21$8,301
FarxigaDapagliflozin Propanediol12$7,913
Spiriva RespimatTiotropium Bromide12$5,953
ArexvyRsvpref3 Antigen/As01e/Pf14$3,802
Janumet XrSitagliptin Phos/Metformin Hcl11$2,966
Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm11$2,297
Levothyroxine Sodium256$2,072
Atorvastatin Calcium293$1,703
Candesartan Cilexetil21$1,611

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$46$46,87325 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy$20$30,27549 claims
Lilly USA, LLCTrulicity$66$11,53812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Bay St Louis

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →